St Louis Truck Driver First in U.S. to get Visian Toric ICL




October 18, 2018

For immediate release

Contact: Jami Palmer Brinton

314-375-2020 (office)

Saint Louis truck driver to be first U.S. patient to receive newly FDA-approved LASIK alternative to correct vision

New Visian Toric ICL corrects nearsightedness and astigmatism; keratoconus patients benefit greatly, too


ST LOUIS, MO (Oct. 18, 2018) – David Cheshire, 37, of Pontoon Beach, IL, has worn glasses since

third grade when his teacher noticed he was lying down to read his books.

“I couldn’t read when I was sitting at my desk,” said David. “I found if I laid down on my back

somehow I could get through my reading assignment a little bit easier. It was a difficult time in

my childhood.”


David’s eyesight never improved, and his astigmatism worsened. After working for years as a

professional truck driver, the long days on the road took a toll on his eyes. He tried wearing

contacts but didn’t like them and couldn’t afford prescription sunglasses.

“Driving down the interstate day in and day out started to cause a lot of strain on my eyes,”

said David. “Exit signs started to get blurry and I knew that I had to take action to fix my



David thought about getting LASIK for years but learned his eyes were too bad to be corrected

with current technology. Upon visiting Brinton Vision, he was thrilled to find out that he was a

candidate to receive the new, FDA-approved Visian Toric Implantable Contact Lens (ICL) to

improve his vision. On Monday, October 22, at Brinton Vision in Creve Coeur, he will become

the first patient in the United States to have a procedure with this technology.


“We are thrilled Brinton Vision was chosen be the first practice in the country to offer this

state-of-the-art medical technology to improve eyesight in patients, like David, who will greatly

benefit from the Visian Toric ICL,” said Jason P. Brinton, MD, founder of Brinton Vision.


The Visian Toric ICL is a biocompatible, implantable contact lens and is the first entrant in a new

category of technology that corrects astigmatism without removing tissue from the eye’s

cornea (as with LASIK) or from the eye’s lens (as with cataract and RLE procedures). Clinical

studies have proven the lens to be a safe and effective treatment for people who are

nearsighted, have astigmatism, and who want a potentially reversible option for lifelong vision



David also has the early stages of keratoconus – a challenging eye disease that causes a variety

of issues, including blurring and distortion of vision. Now, with access to a newly approved

procedure, David’s vision can be cleared, despite his disease.


“The Toric ICL opens up a whole new world visually for patients who have keratoconus,” said

Dr. Brinton. “This lens has been successfully used internationally for years to correct vision in a

subset of patients with this disease and will now be available for the first time in the US – that’s

a big deal to the roughly quarter of a million people in this country who, like David, suffer from

blurry vision due to this eye condition.”


For David, the short Visian Toric ICL procedure will provide the visual freedom and opportunity

to experience life in a way he has only dreamed of since early childhood. He looks forward to

more fully enjoying his love of four-wheeling, go-karting, and hiking with clear vision.

Dr. Jason P. Brinton is an internationally recognized specialist in the field of LASIK and refractive surgery. He is a graduate of Harvard College, earned his medical doctorate from the Harvard Medical School and is board certified by the American Board of Ophthalmology.